Literature DB >> 30822399

Intravital multiphoton microscopic imaging platform for ocular surface imaging.

Yueh-Feng Wu1, Chia-Yi Wang2, Tsung-Lin Yang3, Po-Nien Tsao4, Sung-Jan Lin5, Hsin-Yuan Tan6.   

Abstract

The purpose of this study is to provide an intravital noninvasive multiphoton microscopic platform for long-term ocular imaging in transgenic fluorescent mice with subcellular resolution. A multiphoton microscopic system with tunable laser output was employed. We designed a mouse holder incorporated with stereotaxic motorized stage for in vivo three-dimensional imaging of ocular surface in 3 transgenic mouse line with fluorescent protein (FP) expression to visualize distinct structures. With our imaging platform and the expression of FPs, we obtained the three-dimensional images across the whole cornea from epithelium to endothelium and in conjunctiva with subcellular resolution in vivo. Specified EGFP expression in corneal epithelium of K5-H2B-EGFP mice helped to identify both corneal and limbal epithelial cells while ubiquitous nuclear FP expression in R26R-GR mice allowed us to visualized nuclei of all cell types. Universal membrane-localized FP in mT/mG mice outlined all cell boundaries, nerve fibers, and capillaries. The simultaneously collected second harmonic generation signals from collagenous stroma provided architectural contrast. Time-lapsed recording enabled monitoring the mitotic activity of corneal epithelial cells and limbal epithelial cells. We developed an intravital multiphoton microscopic stereotaxic imaging platform and showed that, by incorporating FP-expressing transgenic mice, this platform enables in vivo 4-dimensional ophthalmic study at subcellular resolution.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Cornea; Endothelium; Keratocytes; Limbal epithelial cells; Nerve; Vessel

Mesh:

Year:  2019        PMID: 30822399     DOI: 10.1016/j.exer.2019.02.016

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  5 in total

1.  Endoplasmic reticulum protein TXNDC5 promotes renal fibrosis by enforcing TGF-β signaling in kidney fibroblasts.

Authors:  Yen-Ting Chen; Pei-Yu Jhao; Chen-Ting Hung; Yueh-Feng Wu; Sung-Jan Lin; Wen-Chih Chiang; Shuei-Liong Lin; Kai-Chien Yang
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

2.  Enhanced angiogenic potential of adipose-derived stem cell sheets by integration with cell spheroids of the same source.

Authors:  Jiashing Yu; Yi-Chiung Hsu; Jen-Kuang Lee; Nai-Chen Cheng
Journal:  Stem Cell Res Ther       Date:  2022-06-28       Impact factor: 8.079

Review 3.  Transgenic models for investigating the nervous system: Currently available neurofluorescent reporters and potential neuronal markers.

Authors:  Michael Yamakawa; Samuel M Santosa; Neeraj Chawla; Evguenia Ivakhnitskaia; Matthew Del Pino; Sebastian Giakas; Arnold Nadel; Sneha Bontu; Arjun Tambe; Kai Guo; Kyu-Yeon Han; Maria Soledad Cortina; Charles Yu; Mark I Rosenblatt; Jin-Hong Chang; Dimitri T Azar
Journal:  Biochim Biophys Acta Gen Subj       Date:  2020-03-12       Impact factor: 3.770

4.  Influence of Human Platelet Lysate on Extracellular Matrix Deposition and Cellular Characteristics in Adipose-Derived Stem Cell Sheets.

Authors:  Nai-Chen Cheng; Yuan-Kun Tu; Ning-Hsu Lee; Tai-Horng Young
Journal:  Front Cell Dev Biol       Date:  2020-10-22

5.  Fibroblast-enriched endoplasmic reticulum protein TXNDC5 promotes pulmonary fibrosis by augmenting TGFβ signaling through TGFBR1 stabilization.

Authors:  Tzu-Han Lee; Chih-Fan Yeh; Ying-Tung Lee; Ying-Chun Shih; Yen-Ting Chen; Chen-Ting Hung; Ming-Yi You; Pei-Chen Wu; Tzu-Pin Shentu; Ru-Ting Huang; Yu-Shan Lin; Yueh-Feng Wu; Sung-Jan Lin; Frank-Leigh Lu; Po-Nien Tsao; Tzu-Hung Lin; Shen-Chuan Lo; Yi-Shuan Tseng; Wan-Lin Wu; Chiung-Nien Chen; Chau-Chung Wu; Shuei-Liong Lin; Anne I Sperling; Robert D Guzy; Yun Fang; Kai-Chien Yang
Journal:  Nat Commun       Date:  2020-08-26       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.